Emmecellofficially Known As Emmetrope Ophthalmics Llcis A Clinical Stage Biotechnology Company Based In Menlo Parkcaliforniafounded In 2011It Focuses On Developing Innovative Cell Based Therapies For Eye Diseasesthe Company Utilizes Its Proprietary Magnetic Cell Deliverymcdnanoparticle Platform To Enhance The Delivery And Integration Of Therapeutic Cellsaiming To Provide Alternatives To Invasive Surgical Procedures Like Corneal Transplants Emmecell S Lead Producteo2002Targets Corneal Edemaa Common Condition That Often Requires Corneal Transplantationthis Therapy Involves Injecting Amplified Donor Corneal Endothelial Cells Into The Eye To Help Restore Visionadditionallyemmecell Operates A Subsidiarycellmpwhich Offers Cgmp Manufacturing Services To Support Biotechnology Startups In The Research And Production Of Cell Therapiesthe Company Collaborates With Organizations Such As Eversight To Optimize The Use Of Donor Tissueenabling Treatments For Multiple Patients From A Single Donor
